一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Bioactive Materials >>article
Bioactive Materials

Bioactive Materials

IF: 18
Download PDF

Reprogramming exosomes for immunity-remodeled photodynamic therapy against non-small cell lung cancer

Published:21 May 2024 DOI: 10.1016/j.bioactmat.2024.05.030
Jiao Guo , Wei Zhao , Xinyu Xiao , Shanshan Liu , Liang Liu , La Zhang , Lu Li , Zhenghang Li , Zhi Li , Mengxia Xu , Qiling Peng , Jianwei Wang , Yuxian Wei , Ning Jiang

Abstract

Traditional treatments against advanced non-small cell lung cancer (NSCLC) with high morbidity and mortality continue to be dissatisfactory. Given this situation, there is an urgent requirement for alternative modalities that provide lower invasiveness, superior clinical effectiveness, and minimal adverse effects. The combination of photodynamic therapy (PDT) and immunotherapy gradually become a promising approach for high-grade malignant NSCLC. Nevertheless, owing to the absence of precise drug delivery techniques as well as the hypoxic and immunosuppressive characteristics of the tumor microenvironment (TME), the efficacy of this combination therapy approach is less than ideal. In this study, we construct a novel nanoplatform that indocyanine green (ICG), a photosensitizer, loads into hollow manganese dioxide (MnO2) nanospheres (NPs) (ICG@MnO2), and then encapsulated in PD-L1 monoclonal antibodies (anti-PD-L1) reprogrammed exosomes (named ICG@MnO2@Exo-anti-PD-L1), to effectively modulate the TME to oppose NSCLC by the synergy of PDT and immunotherapy modalities. The ICG@MnO2@Exo-anti-PD-L1 NPs are precisely delivered to the tumor sites by targeting specially PD-L1 highly expressed cancer cells to controllably release anti-PD-L1 in the acidic TME, thereby activating T cell response. Subsequently, upon endocytic uptake by cancer cells, MnO2 catalyzes the conversion of H2O2 to O2, thereby alleviating tumor hypoxia. Meanwhile, ICG further utilizes O2 to produce singlet oxygen (1O2) to kill tumor cells under 808?nm near-infrared (NIR) irradiation. Furthermore, a high level of intratumoral H2O2 reduces MnO2 to Mn2+, which remodels the immune microenvironment by polarizing macrophages from M2 to M1, further driving T cells. Taken together, the current study suggests that the ICG@MnO2@Exo-anti-PD-L1 NPs could act as a novel drug delivery platform for achieving multimodal therapy in treating NSCLC.

Similar articles

IF:3

A comprehensive review on Brigatinib – A wonder drug for targeted cancer therapy in non-small cell lung cancer

Saudi Pharmaceutical Journal Silky Bedi , Shah A. Khan ,etc Published: 1 September 2018
IF:12.7

Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation.

ACS Central Science Sabrina Baltschukat, Barbara Schacher Engstler,etc Published: 15 May 2019
来凤县| 土默特左旗| 哈巴河县| 七台河市| 远安县| 怀远县| 思茅市| 青浦区| 江孜县| 察哈| 安福县| 伊金霍洛旗| 桐城市| 上虞市| 平罗县| 达尔| 扶风县| 曲松县| 南投县| 原平市| 略阳县| 宁强县| 封开县| 德州市| 华安县| 河西区| 毕节市| 乌拉特中旗| 台北县| 枣阳市| 长阳| 麻城市| 浑源县| 沐川县| 新建县| 陇南市| 珲春市| 锦屏县| 区。| 汤原县| 靖安县|